Review

[Special tumor entities : New results at the 2026 ASCO Annual Meeting].

R. Thölken P. Schuler Johannes Zenk Johannes Doescher

Sep 2026 · HNO (Berlin. Print) · 0 citations

Medicine

TL;DR

The current article critically contextualizes clinically relevant studies presented at the 2026 ASCO Annual Meeting on salivary gland, thyroid, and nasopharyngeal cancer and cutaneous squamous cell carcinoma to support biomarker-based and interdisciplinary treatment pathways.

DOI PubMed Semantic Scholar

View source

Similar papers

Review Oct 2026

[Radiotherapy of head and neck cancer : Highlights from the 2026 ASCO Annual Meeting].

S. Schnellhardt, S. Tribius, Maximilian Linxweiler et al. · HNO (Berlin. Print) · 0 citations

Review Oct 2026

[Nonimmunological systemic therapies in head and neck cancer : Cytotoxic, targeted, EGFR-directed, and supportive approaches at ASCO 2026].

Markus Blaurock, P. Schafhausen, Henrike B. Zech · HNO (Berlin. Print) · 0 citations

Review Oct 2026

[Latest developments in human papillomavirus in head and neck oncology-highlights from the 2026 ASCO Annual Meeting].

S. J. Sharma, M. Suchan, N. J. Galow et al. · HNO (Berlin. Print) · 0 citations

Review Sep 2026

[Surgical trials in head and neck cancer at the 2026 ASCO Annual Meeting].

Miguel Goncalves, A. Knopf, Stephan Hackenberg · HNO (Berlin. Print) · 0 citations

Review Open access Oct 2026

Low-grade serous ovarian cancer: 2026 expert consensus report.

This updated international consensus provides an evidence-based framework for the diagnosis and management of LGSOC while identifying priorities for future clinical research and drug development.

R. Grisham, B. Slomovitz, V. Podder et al. · Gynecologic Oncology · 0 citations

Case report Open access Sep 2026

Primary Salivary Clear Cell Carcinoma with Response to Checkpoint Inhibition: Case Report and Review of the Literature

Abstract Introduction Primary salivary clear cell carcinoma (CCC) is a rare tumor of the minor salivary glands that is often seen as low-grade and responsive to resection. Limited data exist for its response to systemic chemotherapy or immune therapy. Case Presentation A 76-year-old male presented with recurrent, widel...

Samuel F. Schaeffer, M. Mirsky · Case Reports in Oncology · 0 citations